HOXA5 and cervical carcinoma: The results showed that the proliferation-inhibiting ability of HOXA5 in cervical cancer cells was partly abolished upon overexpression of β-catenin in both HOXA5-overexpressing HeLa and SiHa cells (Fig. S6A,, B).